Status:
ACTIVE_NOT_RECRUITING
Evaluation of Anterior Middle Brain Structures With Cerebrovascular Flow in Fetuses With Fetal Growth Restriction
Lead Sponsor:
Ankara Etlik City Hospital
Conditions:
Fetal Growth Retardation
Fetal Neurodevelopmental Disorder
Eligibility:
All Genders
32-37 years
Brief Summary
The study will be conducted to examine the effects of abnormal growth pattern and cerebrovascular blood flow measurements on fetal frontal lobe development with the advancing ultrasound technology. An...
Detailed Description
Fetal growth restriction (FGR) affects up to 10% of all pregnancies. The International Society of Ultrasound in Obstetrics \& Gynecology (ISUOG) adopts the Delphi consensus criteria for the definition...
Eligibility Criteria
Inclusion
- Healthy hearts between the ages of 18-40
- Singleton pregnancies
- 32 to 37 weeks gestational week range
Exclusion
- Multiple pregnancies
- Fetuses with fetal karyotype abnormalities
- Pregnant women with co-morbidity
- Fetuses with fetal intracranial hemorrhage
- Fetuses with cranial anomalies
- Maternal obesity preventing measurement
Key Trial Info
Start Date :
May 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 20 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06215690
Start Date
May 15 2023
End Date
July 20 2024
Last Update
July 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Etlik City Hospital
Ankara, Yenimahalle, Turkey (Türkiye), 06000